Shingles vaccination rates rose during the COVID-19 pandemic, but major gaps remain for underserved groups

Vaccination against shingles increased among adults age 50 and older in the U.S. during the COVID-19 pandemic, but not equally across all population groups. That’s the key finding from a new study my colleagues and I published in the journal Vaccine.

Shingles is caused by the reactivation of the varicella-zoster virus, the same virus that causes chickenpox. It leads to a painful rash and potentially serious complications – especially in older adults – such as persistent nerve…